Financhill
Sell
33

JANX Quote, Financials, Valuation and Earnings

Last price:
$23.71
Seasonality move :
2.62%
Day range:
$23.52 - $25.75
52-week range:
$22.48 - $71.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
105.76x
P/B ratio:
1.42x
Volume:
1.3M
Avg. volume:
995.5K
1-year change:
-46.57%
Market cap:
$1.4B
Revenue:
$10.6M
EPS (TTM):
-$1.36

Earnings Data

Next earnings date for JANX
Aug 07
2025
Most recent earnings per share
-$0.38
Beat by $0.01
(May 8/2025)
Consensus Estimate
-$0.39
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JANX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/07/2025 Q2 $300K -- -- -$0.48 --
05/08/2025 Q1 $650K -- -$0.38 -$0.39 $0.01
12/31/2024 Q4 $1.3M -- -$0.36 -$0.45 $0.09
11/06/2024 Q3 $1.6M $439K -$0.51 -$0.36 -$0.15
08/07/2024 Q2 $863.1K $8.9M -$0.11 -$0.29 $0.18
05/08/2024 Q1 $1M $1.3M -$0.30 -$0.33 $0.03
03/08/2024 Q4 $739.3K $2.5M -$0.24 -$0.39 $0.15
11/07/2023 Q3 -- -- -$0.25 -$0.43 $0.18
08/08/2023 Q2 -- -- -$0.42 -$0.51 $0.09
05/09/2023 Q1 -- -- -$0.42 -$0.47 $0.05
03/10/2023 Q4 -- -- -$0.39 -$0.50 $0.11
11/10/2022 Q3 -- -- -$0.40 -$0.53 $0.13
08/09/2022 Q2 -- -- -$0.41 -$0.39 -$0.02
05/10/2022 Q1 -- -- -$0.32 -- --
03/18/2022 Q4 -- -- -$0.33 -- --
11/09/2021 Q3 -- -- -$0.26 -- --
08/10/2021 Q2 -- -- -$0.62 -- --
03/31/2021 Q1 -- -- -$0.06 -- --
12/31/2020 Q4 -- -- -$0.13 -- --
09/30/2020 Q3 -- -- -$0.10 -- --
06/30/2020 Q2 -- -- -$0.20 -- --
03/31/2020 Q1 -- -- -$0.11 -- --

Janux Therapeutics Earnings Questions

  • How Much did Janux Therapeutics Generate in Revenue Last Quarter?

    Janux Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Janux Therapeutics Beat Earnings Last Quarter?

    Janux Therapeutics announced earnings per share of -$0.38 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Janux Therapeutics Profitable?

    Janux Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Janux Therapeutics EPS Next Year?

    Janux Therapeutics's earnings are forecast to decrease from -$1.28 per share to -$1.30 per share next year representing a decrease of -65.09%.

  • When is Janux Therapeutics's Earnings Date?

    Janux Therapeutics's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
58
TNXP alert for May 28

Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.

Sell
37
ATS alert for May 28

ATS [ATS] is down 1.27% over the past day.

Buy
88
SMR alert for May 28

NuScale Power [SMR] is down 0.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock